These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17356049)

  • 1. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
    Moreno-Luna R; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Jimenez-Gomez Y; Delgado-Lista J; Moreno JA; Tanaka T; Ordovas JM; Lopez-Miranda J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2280-5. PubMed ID: 17356049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism.
    Moreno R; Perez-Jimenez F; Marin C; Moreno JA; Gomez P; Bellido C; Perez-Martinez P; Jimenez-Gomez Y; Fuentes FJ; Lopez-Miranda J
    Atherosclerosis; 2006 Nov; 189(1):163-8. PubMed ID: 16386743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.
    Lai CQ; Demissie S; Cupples LA; Zhu Y; Adiconis X; Parnell LD; Corella D; Ordovas JM
    J Lipid Res; 2004 Nov; 45(11):2096-105. PubMed ID: 15342688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.
    Matsunaga A; Arishima H; Niimura H; Zhang B; Uehara Y; Ohwaki K; Morita M; Hayashida K; Saku K
    Circ J; 2007 May; 71(5):746-52. PubMed ID: 17457003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men.
    Jiménez-Gómez Y; Pérez-Jiménez F; Marín C; Gómez P; Moreno R; Delgado J; Pérez-Martínez P; Gómez MJ; López-Miranda J
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):173-81. PubMed ID: 17399967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
    Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
    Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
    Yin RX; Li YY; Lai CQ
    Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOA5 variants and metabolic syndrome in Caucasians.
    Grallert H; Sedlmeier EM; Huth C; Kolz M; Heid IM; Meisinger C; Herder C; Strassburger K; Gehringer A; Haak M; Giani G; Kronenberg F; Wichmann HE; Adamski J; Paulweber B; Illig T; Rathmann W
    J Lipid Res; 2007 Dec; 48(12):2614-21. PubMed ID: 17768309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica.
    Ruiz-Narváez EA; Yang Y; Nakanishi Y; Kirchdorfer J; Campos H
    J Lipid Res; 2005 Dec; 46(12):2605-13. PubMed ID: 16192625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.
    Perez-Martinez P; Corella D; Shen J; Arnett DK; Yiannakouris N; Tai ES; Orho-Melander M; Tucker KL; Tsai M; Straka RJ; Province M; Kai CS; Perez-Jimenez F; Lai CQ; Lopez-Miranda J; Guillen M; Parnell LD; Borecki I; Kathiresan S; Ordovas JM
    Am J Clin Nutr; 2009 Jan; 89(1):391-9. PubMed ID: 19056598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose added to a fat load suppresses the postprandial triglyceridemia response in carriers of the -1131C and 56G variants of the APOA5 gene.
    Zemánková K; Dembovská R; Piťha J; Kovář J
    Physiol Res; 2017 Nov; 66(5):859-866. PubMed ID: 28730827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apolipoprotein A-IV-360His polymorphism determines the dietary fat clearance in normal subjects.
    Ostos MA; Lopez-Miranda J; Marin C; Castro P; Gomez P; Paz E; Jiménez Perepérez JA; Ordovas JM; Perez-Jimenez F
    Atherosclerosis; 2000 Nov; 153(1):209-17. PubMed ID: 11058717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.
    Sánchez-Moreno C; Ordovás JM; Smith CE; Baraza JC; Lee YC; Garaulet M
    J Nutr; 2011 Mar; 141(3):380-5. PubMed ID: 21209257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE study.
    Hubacek JA; Peasey A; Kubinova R; Pikhart H; Bobak M
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):243-7. PubMed ID: 24462044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome.
    Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B
    Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.